ArticleJournal for immunotherapy of cancer2021
Correction: Targeting PARP-1 with metronomic therapy modulates MDSC suppressive function and enhances anti-PD-1- immunotherapy in colon cancer.
PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.